Patent Law

Patently-O Bits and Bytes: Getting Personal

By Dennis Crouch

• Injured Reserve: I've been on injured reserve for the past few weeks with both arms substantially immobilized, but I am now back (at least until my shoulder surgery next week). I am now going through a load of unread e-mails. If you sent me an e-mail or left a phone message during this time, I will respond as soon as possible. – Dennis Crouch
• Popularity Challenged: It seems that my friends Gene & Renee Quinn have even more friends: Patently-O needs your vote in the ABA popularity contest.
• A bite out of Apple: At least one analyst is suggesting that the Motorola v. Apple patent litigation could "knock 15% off" of Apple's stock price. Florian Mueller has a nice diagram of the Apple lawsuits with Motorola and HTC that are ongoing in the International Trade Commission (ITC), District of Delaware, Southern District of Florida, and the Western District of Wisconsin. Mueller writes about patent challenges to Free & Open Source Software at his FOSS Patent Blog.
• Pioneering Patents: There has been a long debate in the patent world on whether patents should focus more on pioneering patents rather than on smaller "tweaks." Professors Raustiala and Sprigman discuss the issues on the Freakonomics blog.
• Peer-to-Patent on Chemistry and Biotechnology: The Peer-to-Patent system has expanded to include the review of patent applications in areas of chemistry and biotechnology. A recent application up for review was filed by Bayer and claims a Pyrrolotriazine derivative that is apparently useful in treating cancer by inhibiting aurora kinase.  [Try your hand at evaluating patentability of the claimed invention].
  

Full post as published by Patently Obvious on December 08, 2010 (boomark / email).